Trials / Completed
CompletedNCT00693862
Pharmacokinetic Study With Repeated Doses of Stalevo
Levodopa Concentration Profile After Repeated Doses of Stalevo
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- Orion Corporation, Orion Pharma · Industry
- Sex
- All
- Age
- 30 Years – 72 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to show that higher minimum concentration values are obtained following repeated doses of Stalevo 4 times daily compared to lecodopa/carbidopa treatment with corresponding dosing regimen.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | levodopa, carbidopa, entacapone | |
| DRUG | levodopa, carbidopa |
Timeline
- Start date
- 2006-12-01
- Primary completion
- 2008-04-01
- Completion
- 2008-05-01
- First posted
- 2008-06-09
- Last updated
- 2008-06-09
Locations
3 sites across 1 country: Finland
Source: ClinicalTrials.gov record NCT00693862. Inclusion in this directory is not an endorsement.